Today's Analyst Stock Ratings | Upgrades, Downgrades

SPY749.60−0.63%QQQ674.25−0.83%BTC/USD64,547.74+0.68%DIA521.21−0.37%GLD355.70+0.07%TLT79.42+0.05%

							Get Alert
Oct 29, 2026	GKOSGlaukos	$246.75	0.51%	Yi ChenHC Wainwright & Co. 64%	195 248	Previous Buy Current Buy	Get Alert
Oct 29, 2026	GKOSGlaukos	$246.75	-2.74%	Allen GongJP Morgan 48%	200 240	Previous Overweight Current Overweight	Get Alert
Oct 29, 2026	GKOSGlaukos	$246.75	0.1%	Joanne WuenschCitigroup 72%	225 247	Previous Buy Current Buy	Get Alert
Oct 29, 2026	GKOSGlaukos	$246.75	3.34%	Richard NewitterTruist Securities 69%	215 255	Previous Buy Current Buy	Get Alert
Oct 29, 2026	GKOSGlaukos	$246.75	-8.41%	Larry BiegelsenWells Fargo 69%	178 226	Previous Overweight Current Overweight	Get Alert
Oct 29, 2026	GKOSGlaukos	$246.75	-2.74%	Adam MaederPiper Sandler 59%	195 240	Previous Overweight Current Overweight	Get Alert
Oct 29, 2026	GKOSGlaukos	$246.75	-8.81%	Tom StephanStifel 62%	190 225	Previous Buy Current Buy	Get Alert
Oct 29, 2026	GKOSGlaukos	$246.75	-5.17%	Ryan ZimmermanBTIG 71%	205 234	Previous Buy Current Buy	Get Alert
Oct 29, 2026	GKOSGlaukos	$246.75	1.72%	David SaxonNeedham 61%	201 251	Previous Buy Current Buy	Get Alert
Oct 12, 2026	GKOSGlaukos	$246.75	-16.92%	Ryan ZimmermanBTIG 71%	202 205	Previous Buy Current Buy	Get Alert
Sep 22, 2026	GKOSGlaukos	$246.75	-14.89%	Michael SarconeJefferies 50%	190 210	Previous Buy Current Buy	Get Alert
Aug 20, 2026	GKOSGlaukos	$246.75	-18.14%	Ryan ZimmermanBTIG 71%	193 202	Previous Buy Current Buy	Get Alert
Jul 30, 2026	GKOSGlaukos	$246.75	-23%	Michael SarconeJefferies 50%	165 190	Previous Buy Current Buy	Get Alert
Jul 30, 2026	GKOSGlaukos	$246.75	-30.29%	Patrick WoodUBS 54%	150 172	Previous Neutral Current Neutral	Get Alert
Jul 30, 2026	GKOSGlaukos	$246.75	-20.97%	Yi ChenHC Wainwright & Co. 64%	168 195	Previous Buy Current Buy	Get Alert
Jul 30, 2026	GKOSGlaukos	$246.75	-23.81%	Joanne WuenschCitigroup 72%	175 188	Previous Buy Current Buy	Get Alert
Jul 30, 2026	GKOSGlaukos	$246.75	-20.97%	Adam MaederPiper Sandler 59%	165 195	Previous Overweight Current Overweight	Get Alert
Jul 30, 2026	GKOSGlaukos	$246.75	-23%	Tom StephanStifel 62%	175 190	Previous Buy Current Buy	Get Alert
Jul 30, 2026	GKOSGlaukos	$246.75	-12.87%	Richard NewitterTruist Securities 69%	180 215	Previous Buy Current Buy	Get Alert
Jul 30, 2026	GKOSGlaukos	$246.75	-27.86%	Larry BiegelsenWells Fargo 69%	138 178	Previous Overweight Current Overweight	Get Alert
Jul 30, 2026	GKOSGlaukos	$246.75	-18.54%	David SaxonNeedham 61%	150 201	Previous Buy Current Buy	Get Alert
Jul 30, 2026	GKOSGlaukos	$246.75	-21.78%	Ryan ZimmermanBTIG 71%	164 193	Previous Buy Current Buy	Get Alert
Jul 28, 2026	GKOSGlaukos	$246.75	-39.21%	Danielle AntalffyUBS 62%	150	Previous Buy Current Neutral	Get Alert
Jul 17, 2026	GKOSGlaukos	$246.75	-29.08%	Tom StephanStifel 62%	170 175	Previous Buy Current Buy	Get Alert
Jul 16, 2026	GKOSGlaukos	$246.75	-27.05%	Richard NewitterTruist Securities 69%	160 180	Previous Buy Current Buy	Get Alert
Jul 8, 2026	GKOSGlaukos	$246.75	-29.08%	Joanne WuenschCitigroup 72%	162 175	Previous Buy Current Buy	Get Alert
Jul 6, 2026	GKOSGlaukos	$246.75	-31.91%	Yi ChenHC Wainwright & Co. 64%	168	Previous Initiates Current Buy	Get Alert
Jul 1, 2026	GKOSGlaukos	$246.75	-33.13%	Adam MaederPiper Sandler 59%	165 165	Previous Overweight Current Overweight	Get Alert
Jun 17, 2026	GKOSGlaukos	$246.75	-39.21%	David SaxonNeedham 61%	136 150	Previous Buy Current Buy	Get Alert
Jun 11, 2026	GKOSGlaukos	$246.75	-34.35%	Joanne WuenschCitigroup 72%	140 162	Previous Buy Current Buy	Get Alert
Jun 10, 2026	GKOSGlaukos	$246.75	-34.35%	Ryan ZimmermanBTIG 71%	162 162	Previous Buy Current Buy	Get Alert
May 21, 2026	GKOSGlaukos	$246.75	-34.35%	Ryan ZimmermanBTIG 71%	141 162	Previous Buy Current Buy	Get Alert
May 20, 2026	GKOSGlaukos	$246.75	-34.35%	Ryan ZimmermanBTIG 71%	141 162	Previous Buy Current Buy	Get Alert
Apr 30, 2026	GKOSGlaukos	$246.75	-43.26%	Allen GongJP Morgan 48%	120 140	Previous Overweight Current Overweight	Get Alert
Apr 30, 2026	GKOSGlaukos	$246.75	-43.26%	Joanne WuenschCitigroup 72%	135 140	Previous Buy Current Buy	Get Alert
Apr 30, 2026	GKOSGlaukos	$246.75	-44.07%	Larry BiegelsenWells Fargo 69%	135 138	Previous Overweight Current Overweight	Get Alert
Apr 30, 2026	GKOSGlaukos	$246.75	-44.88%	David SaxonNeedham 61%	127 136	Previous Buy Current Buy	Get Alert
Apr 30, 2026	GKOSGlaukos	$246.75	-42.86%	Ryan ZimmermanBTIG 71%	131 141	Previous Buy Current Buy	Get Alert
Feb 18, 2026	GKOSGlaukos	$246.75	-45.29%	Larry BiegelsenWells Fargo 69%	122 135	Previous Overweight Current Overweight	Get Alert
Feb 18, 2026	GKOSGlaukos	$246.75	-48.53%	David SaxonNeedham 61%	125 127	Previous Buy Current Buy	Get Alert
Feb 18, 2026	GKOSGlaukos	$246.75	-46.91%	Ryan ZimmermanBTIG 71%	131 131	Previous Buy Current Buy	Get Alert
Jan 28, 2026	GKOSGlaukos	$246.75	-46.91%	Ryan ZimmermanBTIG 71%	123 131	Previous Buy Current Buy	Get Alert
Jan 22, 2026	GKOSGlaukos	$246.75	-35.16%	Thomas StephanStifel 42%	115 160	Previous Buy Current Buy	Get Alert
Jan 14, 2026	GKOSGlaukos	$246.75	-49.34%	David SaxonNeedham 61%	125 125	Previous Buy Current Buy	Get Alert
Jan 2, 2026	GKOSGlaukos	$246.75	-41.24%	George SellersStephens & Co. 40%	115 145	Previous Overweight Current Overweight	Get Alert
Jan 2, 2026	GKOSGlaukos	$246.75	-52.99%	Ryan ZimmermanBTIG 71%	116 116	Previous Buy Current Buy	Get Alert
Dec 23, 2025	GKOSGlaukos	$246.75	-41.24%	Danielle AntalffyUBS 62%	140 145	Previous Buy Current Buy	Get Alert
Dec 18, 2025	GKOSGlaukos	$246.75	-41.24%	Richard NewitterTruist Securities 69%	120 145	Previous Buy Current Buy	Get Alert
Dec 11, 2025	GKOSGlaukos	$246.75	-49.34%	Joanne WuenschCitigroup 72%	113 125	Previous Buy Current Buy	Get Alert
Dec 9, 2025	GKOSGlaukos	$246.75	-49.34%	David SaxonNeedham 61%	117 125	Previous Buy Current Buy	Get Alert
Oct 30, 2025	GKOSGlaukos	$246.75	-51.37%	Allen GongJP Morgan 48%	110 120	Previous Overweight Current Overweight	Get Alert
Oct 30, 2025	GKOSGlaukos	$246.75	-54.2%	Joanne WuenschCitigroup 72%	110 113	Previous Buy Current Buy	Get Alert
Oct 30, 2025	GKOSGlaukos	$246.75	-50.56%	Larry BiegelsenWells Fargo 69%	120 122	Previous Overweight Current Overweight	Get Alert
Oct 30, 2025	GKOSGlaukos	$246.75	-52.58%	David SaxonNeedham 61%	115 117	Previous Buy Current Buy	Get Alert
Oct 30, 2025	GKOSGlaukos	$246.75	-52.99%	Ryan ZimmermanBTIG 71%	104 116	Previous Buy Current Buy	Get Alert
Oct 27, 2025	GKOSGlaukos	$246.75	-51.37%	Larry BiegelsenWells Fargo 69%	92 120	Previous Equal-Weight Current Overweight	Get Alert
Oct 20, 2025	GKOSGlaukos	$246.75	-57.85%	Ryan ZimmermanBTIG 71%	104 104	Previous Buy Current Buy	Get Alert
Oct 13, 2025	GKOSGlaukos	$246.75	-57.85%	Ryan ZimmermanBTIG 71%	104 118	Previous Buy Current Buy	Get Alert
Oct 7, 2025	GKOSGlaukos	$246.75	-55.42%	Joanne WuenschCitigroup 72%	110 140	Previous Buy Current Buy	Get Alert
Oct 1, 2025	GKOSGlaukos	$246.75	-58.26%	David RomanGoldman Sachs 54%	103	Previous Initiates Current Buy	Get Alert
Sep 22, 2025	GKOSGlaukos	$246.75	-51.37%	Richard NewitterTruist Securities 69%	120 126	Previous Buy Current Buy	Get Alert
Sep 10, 2025	GKOSGlaukos	$246.75	-52.18%	Ryan ZimmermanBTIG 71%	118 118	Previous Buy Current Buy	Get Alert
Jul 31, 2025	GKOSGlaukos	$246.75	-62.72%	Larry BiegelsenWells Fargo 69%	86 92	Previous Equal-Weight Current Equal-Weight	Get Alert
Jul 31, 2025	GKOSGlaukos	$246.75	-45.69%	Danielle AntalffyUBS 62%	125 134	Previous Buy Current Buy	Get Alert
May 6, 2025	GKOSGlaukos	$246.75	-70.82%	Patrick WoodMorgan Stanley 54%	72 110	Previous Underweight Current Underweight	Get Alert
May 2, 2025	GKOSGlaukos	$246.75	-53.39%	Mason CarricoStephens & Co. 60%	115 140	Previous Overweight Current Overweight	Get Alert
May 1, 2025	GKOSGlaukos	$246.75	-53.39%	Thomas StephanStifel 42%	115 140	Previous Buy Current Buy	Get Alert
May 1, 2025	GKOSGlaukos	$246.75	-45.29%	Richard NewitterTruist Securities 69%	135 140	Previous Buy Current Buy	Get Alert
May 1, 2025	GKOSGlaukos	$246.75	-65.15%	Larry BiegelsenWells Fargo 69%	86 160	Previous Overweight Current Equal-Weight	Get Alert
May 1, 2025	GKOSGlaukos	$246.75	-53.39%	David SaxonNeedham 61%	115 176	Previous Buy Current Buy	Get Alert
Apr 16, 2025	GKOSGlaukos	$246.75	-29.08%	Anthony PetroneMizuho 73%	175 200	Previous Outperform Current Outperform	Get Alert
Apr 15, 2025	GKOSGlaukos	$246.75	-33.13%	Matt O'BrienPiper Sandler 52%	165 180	Previous Overweight Current Overweight	Get Alert
Apr 11, 2025	GKOSGlaukos	$246.75	-43.26%	Richard NewitterTruist Securities 69%	140 185	Previous Buy Current Buy	Get Alert
Feb 21, 2025	GKOSGlaukos	$246.75	-35.16%	Larry BiegelsenWells Fargo 69%	153 160	Previous Overweight Current Overweight	Get Alert
Feb 21, 2025	GKOSGlaukos	$246.75	-28.67%	David SaxonNeedham 61%	149 176	Previous Buy Current Buy	Get Alert
Feb 19, 2025	GKOSGlaukos	$246.75	-18.95%	Anthony PetroneMizuho 73%	140 200	Previous Neutral Current Outperform	Get Alert
Jan 27, 2025	GKOSGlaukos	$246.75	-27.05%	Matt O'BrienPiper Sandler 52%	140 180	Previous Overweight Current Overweight	Get Alert
Dec 31, 2024	GKOSGlaukos	$246.75	-29.08%	Thomas StephanStifel 42%	153 175	Previous Buy Current Buy	Get Alert
Dec 18, 2024	GKOSGlaukos	$246.75	-25.03%	Richard NewitterTruist Securities 69%	152 185	Previous Buy Current Buy	Get Alert
Dec 17, 2024	GKOSGlaukos	$246.75	-43.26%	Anthony PetroneMizuho 73%	115 140	Previous Neutral Current Neutral	Get Alert
Dec 11, 2024	GKOSGlaukos	$246.75	-37.99%	Larry BiegelsenWells Fargo 69%	145 153	Previous Overweight Current Overweight	Get Alert
Dec 11, 2024	GKOSGlaukos	$246.75	-34.35%	Joanne WuenschCitigroup 72%	132 162	Previous Neutral Current Buy	Get Alert
Dec 6, 2024	GKOSGlaukos	$246.75	-26.24%	Danielle AntalffyUBS 62%	182	Previous Initiates Current Buy	Get Alert
Dec 2, 2024	GKOSGlaukos	$246.75	-37.99%	Thomas StephanStifel 42%	145 153	Previous Buy Current Buy	Get Alert
Dec 2, 2024	GKOSGlaukos	$246.75	-51.37%	Patrick WoodMorgan Stanley 54%	120	Previous Equal-Weight Current Underweight	Get Alert
Nov 26, 2024	GKOSGlaukos	$246.75	-39.61%	Ryan ZimmermanBTIG 71%	140 149	Previous Buy Current Buy	Get Alert
Nov 5, 2024	GKOSGlaukos	$246.75	-41.24%	Allen GongJP Morgan 48%	130 145	Previous Overweight Current Overweight	Get Alert
Nov 5, 2024	GKOSGlaukos	$246.75	-41.24%	Larry BiegelsenWells Fargo 69%	135 145	Previous Overweight Current Overweight	Get Alert
Oct 14, 2024	GKOSGlaukos	$246.75	-38.4%	Richard NewitterTruist Securities 69%	145 152	Previous Buy Current Buy	Get Alert
Sep 3, 2024	GKOSGlaukos	$246.75	-41.24%	Thomas StephanStifel 42%	130 145	Previous Buy Current Buy	Get Alert
Aug 28, 2024	GKOSGlaukos	$246.75	-43.67%	Ryan ZimmermanBTIG 71%	131 139	Previous Buy Current Buy	Get Alert
Aug 27, 2024	GKOSGlaukos	$246.75	-39.61%	David SaxonNeedham 61%	137 149	Previous Buy Current Buy	Get Alert
Aug 1, 2024	GKOSGlaukos	$246.75	-43.26%	Matt O'BrienPiper Sandler 52%	110 140	Previous Overweight Current Overweight	Get Alert
Aug 1, 2024	GKOSGlaukos	$246.75	-45.29%	Larry BiegelsenWells Fargo 69%	120 135	Previous Overweight Current Overweight	Get Alert
Aug 1, 2024	GKOSGlaukos	$246.75	-41.24%	Richard NewitterTruist Securities 69%	141 145	Previous Buy Current Buy	Get Alert
Aug 1, 2024	GKOSGlaukos	$246.75	-44.48%	David SaxonNeedham 61%	131 137	Previous Buy Current Buy	Get Alert
Jul 16, 2024	GKOSGlaukos	$246.75	-42.86%	Samuel BrodovskyTruist Securities 61%	125 141	Previous Buy Current Buy	Get Alert
Jul 15, 2024	GKOSGlaukos	$246.75	-53.39%	Anthony PetroneMizuho 73%	100 115	Previous Neutral Current Neutral	Get Alert
Jul 15, 2024	GKOSGlaukos	$246.75	-46.91%	Ryan ZimmermanBTIG 71%	112 131	Previous Buy Current Buy	Get Alert
Jul 15, 2024	GKOSGlaukos	$246.75	-51.37%	Patrick WoodMorgan Stanley 54%	100 120	Previous Equal-Weight Current Equal-Weight	Get Alert

Recent Analyst Stock Rating News

National Vision Analysts Cut Their Forecasts Following Q3 Results

National Vision beat Q3 EPS estimates but missed sales, cut FY26 guidance, and saw analysts lower price targets; shares fell 1.5%.

These Analysts Slash Their Forecasts On Cerebras Systems After Q3 Results

Cerebras missed Q3 FY26 estimates but raised revenue guidance to $940M-$960M; shares rose 11.2% as analysts cut price targets.

CrowdStrike To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday

Analysts raised CrowdStrike and Jazz targets, while cutting targets for Cisco, Fermi, Twist Bioscience, Applied Materials, Firefly and Nebius.

This Analog Devices Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Analysts initiated coverage on UCTT, DNLI, HAE, MTRI and ADI, assigning ratings from Equal-Weight to Buy and targets of $33-$505.

This Palo Alto Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Analysts upgraded Ecolab, Autodesk, Domino’s, Palo Alto Networks and Installed Building Products, raising ratings and price targets.

This Lowe's Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday

Analysts downgraded Tractor Supply, Lowe’s, Roblox, NVIDIA and Cognizant, cutting ratings and/or price targets.

NVDA, AMD, CRWV and More: 5 Stocks Investors Couldn’t Stop Buzzing About This Week

tail investors talked up five hot stocks during the week (Nov. 9 to Nov. 13) on X and Reddit's r/WallStreetBets: NVDA, AMD, TSLA, CSCO, CRWV

PRO

Rosenblatt Maintains Buy on NVIDIA, Lowers Price Target to $300

Rosenblatt analyst Kevin Cassidy maintains NVIDIA (NASDAQ:NVDA) with a Buy and lowers the price target from $390 to $300.

PRO

Rosenblatt Maintains Buy on CrowdStrike Holdings, Raises Price Target to $275

Rosenblatt analyst Catharine Trebnick maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Buy and raises the price target from $250 to $275.

PRO

Rosenblatt Maintains Buy on Xometry, Raises Price Target to $140

Rosenblatt analyst Scott Devitt maintains Xometry (NASDAQ:XMTR) with a Buy and raises the price target from $130 to $140.

The Best Trading Research Platform

For Retail Investors and Professional Trades Alike.

Get Started for Free

What Are Analyst Stock Ratings?

Analyst ratings measure the expected performance of a stock during a given time period. Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders.

Analysts arrive at stock ratings after they research companies’ public financial statements, communicate with executives and customers and interact with companies in other ways.

Most analysts issue ratings 4 times a year, usually at 3-month intervals.

How to Use Analyst Ratings

As an investor or trader, you want to be able to use analyst ratings effectively. Here are steps you can take to understand how to synthesize all the information analysts report about a particular company and how to apply it to your own trades.

Step 1: Check Ratings History

In the short term, look to see whether analysts suggest an initiation, upgrade or downgrade for a particular stock. Understand how the rating changed compared to the previous rating and whether a price target gets announced or changed.

Sometimes the rating stays the same and only the price target changes, which could cause the stock to move in either direction, depending on the significance of the change between the 2 price targets.

Step 2: Check for Other News

In the short term, check to see how the stock reacts to positive or negative news. This will be an indication of the company’s outlook because analyst ratings usually come out after the company announces news (it’ll typically be earnings news).

Step 3: Look at the Sector for News

Check to see if other stocks in the sector also received similar ratings. This could indicate micro news, which refers to when the whole sector or specific company trades in a specific way due to news outside of one company.

Step 4: Look at the Note

If available, look over the analyst note itself. The beginning of the note has the main information of the rating and price target. Investors should also take a look at the summary of the note, which you can find in the first couple pages and give you a concrete overview of the company. This can help you get an understanding of how analysts arrived at their thesis on the stock.

An example of an analyst note. Source: Needham

Step 5: Make a Decision

After reviewing the analyst ratings (and whether the analyst proposes a change or initiation) and find the reason for that note. Make a decision based on the analyst thesis on the company. This should give you guidance on how to make your thesis. Analyst ratings are a good indication of what professionals believe the company or sector will do, helping you get a better understanding of the companies you’re interested in.

Analyst Rating Accuracy

Analyst ratings are not set in stone and nobody knows indefinitely what a stock will do. Therefore, analyst ratings should be taken as an educated guess made by professionals who carefully study the specific company and sector in question. It's not a surprise that the accuracy of each rating can vary by each individual analyst and specific ratings on companies.

In other words, there’s no hard number or percentage on how accurate analyst ratings are because they are like educated guesses on what they think the stock will do based on their research, within that particular sector. In addition, each firm has so many analysts and so many different companies to review that you can compare ratings to glean what you believe is the truth.

Where Analyst Ratings Come From

Analyst ratings come from stock analysts. Analysts “go deep” on companies within a particular industry or sector. Some analysts employ a top-down approach (they start with an industry or sector and look for excellent companies within that industry or sector) and other stock analysts choose a bottom-up approach, which means they start with the company first and connect the dots within that company’s sector or industry. Analysts evaluate:

Financial statements
Economic fundamentals
Suppliers, customers and competitors
Management quality
Business model
Revenue
Expenses
Assets
Liabilities

While these evaluations are done using facts and figures that any investor can access, they come down to a conclusion the analyst must draw. While this isn’t an unqualified opinion, analysts will disagree because their interpretations of the data could vary.

Types of Stock Ratings

Stock ratings can range from simple “buy” and “sell” ratings to “equal weight” and “outperform” ratings. Here’s a quick overview of how analysts rate stocks.

Buy Rating

A “buy” rating indicates that an analyst is optimistic about a stock’s short-term or mid-term growth and recommends that traders purchase the stock. An analyst may even go so far as to indicate that a stock is a “strong buy.” At the same time, you may choose to swing trade the asset for a profit and come back later to start the process all over again.

Sell Rating

A “sell” rating means that an analyst believes the stock will trend downward in a particular time frame. Analysts might even refer to a security as a “strong sell.” Remember, though, you may want to swing trade and come back to this asset in the future even though you just chose to sell, just as you would under a “buy” rating.

Hold

A “hold” rating suggests that investors should not buy more of or sell the specified stock because they believe the stock should perform in a way that’s consistent with the market or will perform similarly to comparable companies within that particular sector. This is akin to the value investing approach that Warren Buffett uses, looking to gain long-term value from a single stock rather than flipping it because of a bad week. As many have said, it’s not a loss until you sell.

Underperform

An “underperform” rating means an analyst indicates that a stock is expected to perform below the market or sector average. And yes, while the underperform rating may not bode well for an asset in the next few weeks, it may not stay that way. Continue to carefully monitor your portfolio to ensure that an underperforming asset hasn’t turned itself around. As companies are faced with the Herculean task of pleasing shareholders, they will push to fix their underperforming stocks, meaning that a stock you wrote off could rise again.

Outperform

An “outperform” rating means that an analyst expects a stock to outperform the market or sector average. While the stock may look to outperform the market or a sector’s average, that doesn’t mean it will continue to soar forever. You must look at an outperform rating as what that asset will do in recent times, but it may not maintain that trajectory.

Equal-Weight

An equal weight rating means that an analyst believes that an individual stock's performance will tie to the average of all the stocks that an analyst covers in that particular sector. This type of rating helps investors get a true comparison of stocks to each other within a particular sector or industry. At the same time, equal-weight ratings could change at any time.

Price Target

A price target is an analyst’s projection of a stock’s future price. A price target is generally set up in a general trade or area where the asset might land. This means that the analyst could get close without hitting the figure on the head. Even so, the analyst wants to get close and better predict the movement of the marketplace and the asset.

Understanding Stock Ratings

Stock ratings are assessments of the investment potential of a particular stock. They are typically created by financial analysts who evaluate a company's financial performance, competitive positioning, and market outlook to provide guidance on the stock's expected future performance.

Ratings typically range from "buy" to "sell," with variations in between, such as "hold," "accumulate," or "neutral." A "buy" rating suggests that the stock is likely to perform well in the future, and investors should consider purchasing it. Conversely, a "sell" rating indicates that the stock is expected to underperform, and investors should consider selling it.

It's important to note that ratings are not guarantees of performance and should not be relied upon solely when making investment decisions. Ratings are just one factor to consider when evaluating a stock's potential, and investors should also conduct their own research and analysis to make informed decisions.

Another thing to keep in mind is that different analysts may have different opinions on a stock, so it's a good idea to consider multiple ratings before making an investment decision.

In addition to analyst ratings, investors can also consider other factors when evaluating a stock, such as its financial statements, management team, industry trends, and overall market conditions. By combining all of these factors, investors can make informed decisions about which stocks to buy or sell.

In summary, stock ratings are an important tool for investors to consider when evaluating a stock's potential, but they should not be the only factor used in investment decision-making. It's important to conduct your own research, consider multiple ratings, and take into account other factors before making an investment decision.

Should You Use Analyst Ratings to Inform Your Own Trades?

You can definitely use analyst ratings to inform your own trades and inform your own thesis but it’s a good idea to do your own research. However, analyst ratings are just one step in what should be a much larger investment strategy. Don’t fall in love with just one analyst. Compare notes. Look into how these ratings match with activity on the market and current events. Plus, remember that an analyst rating could easily be incorrect. No one is perfect, but these ratings are a good place to start.

Visit Benzinga News for more guidance on how to research companies and make decisions about research, trading and investing.

Compare Online Stock Brokers

Claim Exclusive Offers

Interactive Brokers Review
Good Fit For:
Active and Global Traders
VIEW PROS & CONS:
Securely through Interactive Brokers’ website
Plus500 Review
Good Fit For:
Leveraged Trading
VIEW PROS & CONS:
securely through Plus500 Yield's website
public.com Review
Good Fit For:
Trading Ideas
VIEW PROS & CONS:
securely through public.com's website
Robinhood Review
Good Fit For:
Commission-Free Mobile Trading
VIEW PROS & CONS:
securely through Robinhood's website
TradeZero Review
Good Fit For:
Active Short Sellers
VIEW PROS & CONS:
securely through TradeZero [SPONSORED]'s website